Chinese PE firm Yunfeng Capital has led a $120 million Series E round of funding for Xiaozhu.com, a Beijing-based short-term rentals platform.
Xiaozhu.com said in a statement that it is now valued at in excess of $1 billion. Existing investors including Joy Capital, Morningside Venture Capital, and Capital Today China Group also participated...
Hangzhou-based drug developer Sumgen Biotech has raised RMB220 million ($32 million) in a Series B funding led by Addor Capital.
Increased climate change awareness on a corporate level is leading to more investment – either direct or through funds – in start-ups that offer mitigation solutions. Asia is a key geography
Healthcare-focused Panacea Venture has led a $40 million Series C round for China’s XWPharma, a neurobiology-focused biotech developer previously known as XW Laboratories.
Kyee Technology, a Chinese digital medical platform has raised RMB430 million ($64 million) in a Series D round led by Tencent Holdings. Other investors include Longmen Capital, Dyee Capital and Royal Sea Capital.